About Contact Us Careers

Neuralgia Drugs Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3469
Published Date: Aug 28, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Neuralgia Drugs Landscape

Pfizer, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Novartis AG
Biogen Inc.
Cadila Healthcare Limited
Lundbeck Pharmaceuticals LLC
GlaxoSmithKline PLC
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Endo Pharmaceuticals Inc.
Teikoku Pharma USA, Inc.

Browse Key Market Insights with Data Illustration:

Neuralgia Drugs Market Size, Growth Report 2036

In the News

August 2021- Yuyu Pharma and Novartis Korea entered into an agreement in which Yuyu acquired the exclusive distribution rights for 3 prescription medicines, including Tegretol, a medicine containing carbamazepine used to treat conditions including epilepsy and trigeminal neuralgia.

Author Credits: Radhika Pawar

Report ID: 3469
Published Date: Aug 28, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Neuralgia Drugs Market size is poised to grow at over 6.3% CAGR during the forecast period i.e., between 2024-2036.

The market growth is impelled by growing prevalence of trigeminal neuralgia and increasing incidence rate of diabetes around the world.

Asia Pacific is poised to dominate majority revenue share by 2036, on the back of increasing occurrence of diabetes and rising elderly population in the region.

The major players in the market are Pfizer, Inc., Novartis AG, Biogen Inc., Cadila Healthcare Limited, Lundbeck Pharmaceuticals LLC, and others.

Inquiry Before Buying Request Free Sample